“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.
Ethicists, humanists, lawyers and patients should come together to understand the risk of data in healthcare and whether patients are willing to take that risk, Pierre Meulien told EURACTIV.com.
The Maltese EU presidency will seek more transparency in the way pharmaceutical companies negotiate with member states on medicines’ pricing, Health Minister Chris Fearne said in an interview with EURACTIV.
A new breed of drugs, called “value added medicines”, could help patients improve their everyday life while in treatment, without increasing healthcare budgets, Christoph Stoller said in an interview with EURACTIV.com
The internet provides a vast marketplace for new dangerous substances and drug prevention authorities risk being left in the wake of dealers and distributors, warned the head of the EMCDDA, Alexis Goosdeel. EURACTIV Germany reports.
Ken Gabriel has dedicated his life to innovation and entrepreneurship at Google, and the Defence Advanced Research Projects Agency (DARPA). For Gabriel innovation boils down to “satisfying an unmet need”.
